ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000231327.1	ABT-263 (navitoclax)	Breast invasive carcinoma	0.023455403	Sensitive
ENSG00000231327.1	ABT-263 (navitoclax)	Ovarian serous cyStomach adenocarcinomaenocarcinoma	0.038927222	Sensitive